Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
NCT ID: NCT00091481
Last Updated: 2007-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
201 participants
INTERVENTIONAL
2003-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zemplar
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients on Hemodialysis requiring treatment for secondary hyperparathyroidism with vitamin D therapy
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jin Tian, M.D.
Role: STUDY_DIRECTOR
Abbott
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Errikos Dynan Hospital
Ambelokipi, Athens, Greece
General Hospital of Athens, "G.Gennimatas"
Cholargós, Athens, Greece
General Hospital of Attica "Sismanoglio"
Marousi, Athens, Greece
"Hygeia" Diagnosis and Therapy Center
Marousi, Athens, Greece
General Hospital of Melissia "Amalia Fleming"
Melíssia, Athens, Greece
General Hospital of Voula Askilpieion
Voula, Athens, Greece
General Hospital of Heraklion
Voutes, Heraklion, Crete, Greece
General Hospital Thessaloniki "Papanikolaou"
Eksochi, Thessaloniki, Greece
General Hospital of Veria
Papagou Area, Veria, Greece
Blue Cross Clinic
Athens, , Greece
Evgenidio Clinic
Athens, , Greece
Regional General Hospital of Athens "Korgialeneio-Benakeio"
Athens, , Greece
General University Hospital of Alexandroupolis
Dragana, , Greece
Regional General Hospital of Ioannina "Hatzikosta"
Ioannina, , Greece
General University Hospital Ioannina
Ioannina, , Greece
General Hospital of Nikea "Agios Panteleimon"
Nikea, Piraeus 18454,, , Greece
General Hospital of Thessaloniki "Ahepa"
Thessaloniki, , Greece
General Hospital of Thessaloniki "Hippokrateion"
Thessaloniki, , Greece
General Hospital of Thessaloniki "Papageorgiou"
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M01-367
Identifier Type: -
Identifier Source: org_study_id